Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Washington D.C. DC, Philadelphia PA, Pittsburgh PA,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting

Mindful Self-Compassion for Anxiety Disorders and Depression

for
Anxiety Disorders, Generalized Anxiety Disorder,
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18 - 70+

Code: NCT05671419

Recruiting

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities

for
Periprosthetic Joint Infections
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Elute, Inc.

Sex: All

Age: 22+

Code: NCT05361941

Recruiting

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Washington D.C. DC, Pittsburgh PA, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06615479

Phase 3, Recruiting

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: Washington D.C. DC, Philadelphia PA, New Brunswick NJ,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: All

Age: 18+

Code: NCT01042379

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase 1, Phase 2, Recruiting

Tobacco Education and Lung Health Study (TEAL)

for
Smoking Cessation
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 50 - 70+

Code: NCT06290869

Phase 3, Recruiting

ETHAN - ET for Male BC

for
Male Breast Cancer, Hormone Receptor-positive Breast Cancer,
Location: Washington D.C. DC, Philadelphia PA, Pittsburgh PA,
Sponsor: Jose Pablo Leone

Sex: Male

Age: 18+

Code: NCT05501704

Phase 2, Recruiting

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

for
Uveal Melanoma
Location: Washington D.C. DC, Pittsburgh PA, Columbus OH,
Sponsor: Diwakar Davar

Sex: All

Age: 18+

Code: NCT06070012

Phase 2, Recruiting

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

for
Breast Cancer, HER2-low Breast Cancer, Metastatic Breast Cancer,
Location: Washington D.C. DC, The Bronx NY, Chapel Hill NC,
Sponsor: Ana C Garrido-Castro, MD

Sex: All

Age: 18+

Code: NCT06533826

Phase 2, Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05118789

Phase 1, Phase 2, Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06706076

Phase 1, Phase 2, Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Washington D.C. DC, Fairfax VA, New York NY, Boston MA,
Sponsor: Sutro Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07227168

Phase 1, Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Washington D.C. DC, Baltimore MD, Somerville NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase 2, Phase 3, Recruiting

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for
PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC,
Location: Washington D.C. DC, Fairfax VA, New York NY,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06922591

Phase 1, Phase 2, Recruiting

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis

for
Sinus Infection, Acute Sinusitis
Location: Washington D.C. DC, Hershey PA, Richmond VA, Madison WI,
Sponsor: Daniel Merenstein

Sex: All

Age: 18 - 70+

Code: NCT06076304

Recruiting

Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training

for
Visual Field Defect, Stroke, Hemianopia, Quadrantanopia,
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT07105358

Recruiting

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

for
COVID-19 Infection
Location: Washington D.C. DC, Silver Spring MD, Baltimore MD,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07013474

Phase 3, Recruiting

Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

for
Immune Thrombocytopenia (ITP)
Location: Washington D.C. DC, Greenville NC, Boston MA
Sponsor: Nuvig Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07095127

Phase 2, Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Washington D.C. DC, Fairfax VA, Morgantown WV,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07029399

Phase 1, Recruiting